US Patent Issued to JUSTUS-LIEBIG-UNIVERSITAET GIESSEN on May 19 for "Antibiotic selectively kills gram-negative pathogens" (German Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,587, issued on May 19, was assigned to JUSTUS-LIEBIG-UNIVERSITAET GIESSEN (Giessen, Germany).

"Antibiotic selectively kills gram-negative pathogens" was invented by Till Schaberle (Giessen, Germany), Zerlina G. Wuisan (Giessen, Germany), Nils Bohringer (Engelskirchen, Germany) and Luis J. Linares-Otoya (Giessen, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention is concerning a medical preparation comprising bicyclic heptapeptides for use in vertebrates or humans suffering from an infection caused by Gram-negative bacteria like Pseudomonas aeruginosa, Klebsiella pneumoniae, Acineto-bacter baumannii, Neisseria gonorrhoeae, Chlamydia ...